New natural product based entries to treatment of bacterial respiratory tract infections
Expanding the library of broad-spectrum antibiotics is a central component of combating bacterial respiratory tract infections. By extension, this pursuit is also directed at poverty reduction in the developing world as it is intrinsically linked to infectious diseases. To this end, the proposed project aims at advancing natural products with known activity against multi-drug resistant bacteria towards clinical relevance. We will develop efficient chemical syntheses (total and semi-synthetic routes) to access compounds that are not available through other means for biological and mechanistic investigation. The mechanistic work will be used to guide the development of improved and/or simplified structural analogs that can be used at a lower cost. Understanding how to rationally design complex phenylalanine mimetics and oleane triterpenoid structures in this context provides entries to rational development of new generations of small molecule antibiotics working through the same mechanism. The work is enabled by an interdisciplinary collaboration between synthetic chemists in Sweden and Uganda, natural product chemists in Mexico, and microbiologists in South Africa.
- Project ID
SE-0-29-2016-05685_2-285-12182
- Activity status
- 2 - Implementation
- Aid type
- D02 - Other technical assistance
- % to Uganda
- 100.00
Organisations
- Funding
- Sweden
- Implementing
- Lunds universitet
- Extending
- None
Disbursements by fiscal year, quarter
Fiscal year |
Fiscal quarter |
Value (USD) |
Uganda Value (USD) |
2018 |
Q2 |
52,650.05 |
52,650.05 |
2017 |
Q2 |
70,200.07 |
70,200.07 |
Commitments by fiscal year, quarter
Fiscal year |
Fiscal quarter |
Value (USD) |
Uganda Value (USD) |
2016 |
Q3 |
210,600.21 |
210,600.21 |
MTEF projections by fiscal year
Fiscal year |
Value (USD) |
Uganda Value (USD) |
CRS code |
% |
Medical research
(12182)
|
100.0
|